Lori Anne Kunkel is of Oric Pharmaceuticals, Inc.. Currently has a direct ownership of 20,500 shares of ORIC, which is worth approximately $196,595. The most recent transaction as insider was on Jun 03, 2024, when has been sold 20,500 shares (Common Stock) at a price of $3.75 per share, resulting in proceeds of $76,875. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.5K
0% 3M change
n/a 12M change
Total Value Held $196,595

Lori Anne Kunkel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2024
BUY
Exercise of conversion of derivative security
$76,875 $3.75 p/Share
20,500 Added 50.0%
20,500 Common Stock

Also insider at

CRIS
CURIS INC Healthcare
NRIX
Nurix Therapeutics, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
LAK

Lori Anne Kunkel

San Francisco, CA

Track Institutional and Insider Activities on ORIC

Follow Oric Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORIC shares.

Notify only if

Insider Trading

Get notified when an Oric Pharmaceuticals, Inc. insider buys or sells ORIC shares.

Notify only if

News

Receive news related to Oric Pharmaceuticals, Inc.

Track Activities on ORIC